Zobrazeno 1 - 10
of 77
pro vyhledávání: '"G. L. Amidon"'
Autor:
J. P. Skelly, G. A. Van Buskirk, D. R. Savello, G. L. Amidon, H. M. Arbit, S. Dighe, M. B. Fawzi, M. A. Gonzalez, A. W. Malick, H. Malinowski, R. Nedich, G. E. Peck, D. M. Pearce, V. Shah, R. F. Shangraw, J. B. Schwartz, J. Truelove
Publikováno v:
Pharmaceutical Research. 10:313-316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8c2d47132cc5fb993f6aed159fbcc63
https://doi.org/10.1023/a:1018915700942
https://doi.org/10.1023/a:1018915700942
Autor:
E, Jantratid, S, Strauch, C, Becker, J B, Dressman, G L, Amidon, H E, Junginger, S, Kopp, K K, Midha, V P, Shah, S, Stavchansky, D M, Barends
Publikováno v:
Journal of pharmaceutical sciences. 99(4)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing doxycycline hyclate are reviewed. According to the Biopharmaceutics Classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ee307b5bf8ef5799291e905f381dbc5
https://pubmed.ncbi.nlm.nih.gov/19798752
https://pubmed.ncbi.nlm.nih.gov/19798752
Autor:
C, Becker, J B, Dressman, G L, Amidon, H E, Junginger, S, Kopp, K K, Midha, V P, Shah, S, Stavchansky, D M, Barends
Publikováno v:
Journal of pharmaceutical sciences. 97(9)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing pyrazinamide as the only active pharmaceutical ingredient (API) are review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7566f2da8817a43a3cf8dc83336d2a6
https://pubmed.ncbi.nlm.nih.gov/18271031
https://pubmed.ncbi.nlm.nih.gov/18271031
Autor:
C, Becker, J B, Dressman, G L, Amidon, H E, Junginger, S, Kopp, K K, Midha, V P, Shah, S, Stavchansky, D M, Barends
Publikováno v:
Journal of pharmaceutical sciences. 97(4)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing ethambutol dihydrochloride as the only active pharmaceutical ingredient (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6004e6036001aaa9e54ca84eb495dac2
https://pubmed.ncbi.nlm.nih.gov/17879380
https://pubmed.ncbi.nlm.nih.gov/17879380
Autor:
C, Becker, J B, Dressman, G L, Amidon, H E, Junginger, S, Kopp, K K, Midha, V P, Shah, S, Stavchansky, D M, Barends
Publikováno v:
Journal of pharmaceutical sciences. 96(3)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing isoniazid as the only active pharmaceutical ingredient (API) are reviewed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::888646f525a4680720c92ad32913197a
https://pubmed.ncbi.nlm.nih.gov/17117431
https://pubmed.ncbi.nlm.nih.gov/17117431
Publikováno v:
Die Pharmazie. 61(8)
The aim of this paper was to investigate the in vivo dissolution behavior of ketoprofen, a Class II drug according to the Biopharmaceutics Classification System (BCS), in the upper small intestine of dogs. An intubations method was used, where no blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9262813b4ae94e8fa8b07e36e70a8015
https://pubmed.ncbi.nlm.nih.gov/16964708
https://pubmed.ncbi.nlm.nih.gov/16964708
Publikováno v:
Journal of pharmaceutical sciences. 95(5)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing amitriptyline hydrochloride are reviewed. Its therapeutic uses, its pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9f154ddb73843619a067399fffb9a3b
https://pubmed.ncbi.nlm.nih.gov/16557529
https://pubmed.ncbi.nlm.nih.gov/16557529
Autor:
E, Jantratid, S, Prakongpan, J B, Dressman, G L, Amidon, H E, Junginger, K K, Midha, D M, Barends
Publikováno v:
Journal of pharmaceutical sciences. 95(5)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing cimetidine are reviewed. According to the current Biopharmaceutics Classif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7a46b6b60aaf8d93fb7dc638b883df9
https://pubmed.ncbi.nlm.nih.gov/16557528
https://pubmed.ncbi.nlm.nih.gov/16557528
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 299(2)
The proton-coupled oligopeptide transporter (PEPT1) has been shown to mediate mucosal cell transport of di- and tripeptide, and some peptidomimetic drugs. In this study, we determined the correlation between PEPT1 protein expression and the permeabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdea05418dd1243b191c66f1743c46d2
https://pubmed.ncbi.nlm.nih.gov/11602669
https://pubmed.ncbi.nlm.nih.gov/11602669
Autor:
N, Takamatsu, O N, Kim, L S, Welage, N M, Idkaidek, Y, Hayashi, J, Barnett, R, Yamamoto, E, Lipka, H, Lennernäs, A, Hussain, L, Lesko, G L, Amidon
Publikováno v:
Pharmaceutical research. 18(6)
To determine the human jejunal permeability of cimetidine and ranitidine using a regional jejunal perfusion approach, and to integrate such determinations with previous efforts to establish a baseline correlation between permeability and fraction dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6b6de641ff38c81e243cf6b194c6928
https://pubmed.ncbi.nlm.nih.gov/11474776
https://pubmed.ncbi.nlm.nih.gov/11474776